Neurodegenerative Diseases  >>  Cogane (sarsasapogenin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cogane (sarsasapogenin) / IXICO
NCT00130429: Safety and Effect on Memory of PYM50028 in Mild Alzheimer's Disease

Completed
2
250
Europe
PYM50028
Phytopharm
Alzheimer's Disease
 
09/05
CONFIDENT-PD, NCT01060878 / 2010-018534-44: Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease

Completed
2
425
US, Canada, Europe, RoW
PYM50028, Placebo
Phytopharm
Parkinson's Disease
12/12
12/12

Download Options